Larson RA - Search Results

1

The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup study.

Larson RA, Day RS, Azarnia N, Bennett JM, Browman G, Goldberg J, Gottlieb A, Grunwald H, Miller K, Raza A, et al. Larson RA, et al. Br J Haematol. 1992 Oct;82(2):337-46. doi: 10.1111/j.1365-2141.1992.tb06427.x. Br J Haematol. 1992. PMID: 1419816 Clinical Trial.

2

The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure.

Preisler HD, Larson RA, Raza A, Browman G, Goldberg J, Vogler R, Day R, Gottlieb A, Vardiman JW, Bennett J, et al. Preisler HD, et al. Among authors: larson ra. Br J Haematol. 1991 Nov;79(3):390-7. doi: 10.1111/j.1365-2141.1991.tb08046.x. Br J Haematol. 1991. PMID: 1751366

3

Long-term outcome of patients with acute myelogenous leukemia: the role of maintenance therapy, consolidation therapy and the predictive value of two in vitro assays.

Raza A, Preisler HD, Browman GP, Larson RA, Rustum YM, Goldberg J, Vogler R, Miller KA, Bennett J, Kukla C. Raza A, et al. Among authors: larson ra. Leuk Lymphoma. 1993 May;10(1-2):57-66. doi: 10.3109/10428199309147357. Leuk Lymphoma. 1993. PMID: 8374524

4

Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemia.

Raza A, Preisler HD, Li YQ, Larson RA, Goldberg J, Browman G, Bennett J, Grunwald H, Vogler R, Kukla C. Raza A, et al. Among authors: larson ra. Am J Hematol. 1993 Apr;42(4):359-66. doi: 10.1002/ajh.2830420406. Am J Hematol. 1993. PMID: 8493986

5

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

Larson RA, Boogaerts M, Estey E, Karanes C, Stadtmauer EA, Sievers EL, Mineur P, Bennett JM, Berger MS, Eten CB, Munteanu M, Loken MR, Van Dongen JJ, Bernstein ID, Appelbaum FR; Mylotarg Study Group. Larson RA, et al. Leukemia. 2002 Sep;16(9):1627-36. doi: 10.1038/sj.leu.2402677. Leukemia. 2002. PMID: 12200674 Clinical Trial.

6

Alteration of the proliferative rate of acute myelogenous leukemia cells in vivo in patients.

Preisler HD, Raza A, Larson RA. Preisler HD, et al. Among authors: larson ra. Blood. 1992 Nov 15;80(10):2600-3. Blood. 1992. PMID: 1421377 Free article.

7

Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia.

Spielberger RT, Dickstein JI, Le Beau MM, Larson RA, Daly KM, Vardiman JW, Golomb HM. Spielberger RT, et al. Among authors: larson ra. Br J Haematol. 1993 Mar;83(3):519-20. doi: 10.1111/j.1365-2141.1993.tb04680.x. Br J Haematol. 1993. PMID: 8485059 No abstract available.

8

Hypersensitivity reaction to high-dose cytarabine.

Williams SF, Larson RA. Williams SF, et al. Among authors: larson ra. Br J Haematol. 1989 Oct;73(2):274-5. doi: 10.1111/j.1365-2141.1989.tb00267.x. Br J Haematol. 1989. PMID: 2530999 No abstract available.

9

Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine.

Larson RA, Wernli M, Le Beau MM, Daly KM, Pape LH, Rowley JD, Vardiman JW. Larson RA, et al. Blood. 1988 Oct;72(4):1333-9. Blood. 1988. PMID: 3167210 Free article.

10

Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia.

Winter JN, Variakojis D, Gaynor ER, Larson RA, Miller KB. Winter JN, et al. Among authors: larson ra. Cancer. 1985 Aug 1;56(3):443-9. doi: 10.1002/1097-0142(19850801)56:3<443::aid-cncr2820560305>3.0.co;2-q. Cancer. 1985. PMID: 3859362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

633 results

Search Page

Filters